Hongye (Eve) Mao

Hongye (Eve) Mao

Associate

Hongye (Eve) Mao

Associate

  • Overview

    Biography

    Hongye (Eve) Mao is a member of the firm’s Business Transactions Group and its Capital Markets + Securities team. Prior to joining Robinson+Cole, Eve participated in a research program at a New York law firm in a specialty practice group that represents Chinese companies doing business and/or listing their securities in the U.S., as well as U.S. companies with operations and activities in China. Her experience includes drafting Form S-1s and transactional documents for SEC registration, including SPAC IPOs; applying for Nasdaq tickers, Nasdaq application listings, and CUSIP numbers; and conducting research on SPAC precedents, SEC statements and related legal issues. Previously, Eve worked as a Legal Fellow of the Financial Frauds Bureau in the District Attorney’s Office of Manhattan County in New York.

    Eve has worked as a legal intern at a law firm in Shanghai, China, where she conducted legal research on civil procedures and labor law issues, reviewed employment and commercial contracts for compliance with Chinese contract law, labor law and cross-border payment regulations, drafted labor contracts and confidentiality agreements, and translated legal documents regarding dispute resolution, including judgments, contracts and evidence to be used in court.

    Eve also was an extern with Administrative Law Judges at the National Labor Relations Board in Washington, D.C. While there, she was responsible for conducting legal research on labor law issues from past NLRB decisions, preparing bench memoranda and drafting orders and opinions for the Chamber of Senior Judges.

  • Experience
    • Experience

      Experience

      • Represented Prime Number Capital LLC, the lead underwriter in an initial public offering of Phoenix Motor Inc., a California-based company that designs, assembles, and integrates electric drive systems and light- and medium-duty electric vehicles. The firm’s Capital Markets + Securities Team advised Prime Number on the offering, with aggregate gross proceeds of $15.75M, announced on June 7, 2022.

  • NEWS + PRESS
    • News

      R+C in the News

      • October 11, 2023

        Robinson+Cole Represents EF Hutton as the Sole Book-Running manager in Quetta Acquisition Corp. IPO

        • » more info

          Robinson+Cole Represents EF Hutton as the Sole Book-Running manager in Quetta Acquisition Corp. IPO

          Robinson+Cole’s Capital Markets + Securities Team (the Team) was pleased to represent EF Hutton, division of Benchmark Investments, LLC, as the sole book-running manager in the initial public offering of Quetta Acquisition Corp. (Quetta), a special purpose acquisition corporation incorporated in the Cayman Islands. On October 11, 2023, Quetta completed its $69 million IPO of 6,900,000 units at $10 per unit (including units sold upon the full exercise of the underwriters’ over-allotment option). The units began trading on the Nasdaq Capital Market under the ticker symbol “QETA” on October 6, 2023. The Team advising on the offering was led by partners Arila E. Zhou and Ze'-ev E. Eiger and supported by team members Tiange (Tim) Chen and Hongye (Eve) Mao. Read more.

        • View article
      • April 20, 2023

        Capital Markets + Securities Team Represents Top KingWin in IPO

        • » more info

          Capital Markets + Securities Team Represents Top KingWin in IPO

          Robinson+Cole’s Capital Markets + Securities Team (the Team) was pleased to represent Top KingWin Ltd, a provider of capital market related education and support services, in its recent initial public offering. Top KingWin is a company whose main clients are entrepreneurs and executives in small and medium-sized enterprises in China. Services provided by Top KingWin to its clients including corporate business training services, corporate consulting services, and advisory and transaction services. Its mission is to provide comprehensive services to address clients’ needs throughout all phases of their development and growth. On April 20, 2023, Top KingWin completed its $11 million IPO of 2,750,000 Class A ordinary shares at $4.00 per share. The Class A ordinary shares began trading on the Nasdaq Capital Market under the ticker symbol “TCJH” on April 18, 2023. Led by Team Chair Mitchell Lampert, the members advising on this offering were Anna Jinhua Wang, Hongye (Eve) Mao and Zhe (Emmett) Tan. Read more.

        • View article
      • March 17, 2023

        Capital Markets + Securities Team Represents ICZOOM Group Inc. in IPO

        • » more info

          Capital Markets + Securities Team Represents ICZOOM Group Inc. in IPO

          Robinson+Cole’s Capital Markets + Securities Team (the Team) was pleased to represent ICZOOM Group Inc. (ICZOOM), a company engaged in sales of electronic component products to customers in Hong Kong and mainland China through its B2B e-commerce trading platform, in its recent initial public offering. On March 17, 2023, ICZOOM completed its $6 million IPO of 1,500,000 Class A ordinary shares at $4.00 per share. The Class A ordinary shares began trading on the Nasdaq Capital Market under the ticker symbol “IZM” on March 15, 2023. The Team advising on this offering were Arila Zhou, Anna Jinhua Wang, Yang Xu, Emmett Tan and Eve Mao. Read more.

        • View article
      • March 14, 2023

        Capital Markets + Securities Team Serves as Underwriting Counsel in Xiao-I Corporation IPO

        • » more info

          Capital Markets + Securities Team Serves as Underwriting Counsel in Xiao-I Corporation IPO

          Robinson+Cole’s Capital Markets + Securities Team (the Team) served as counsel to Prime Number Capital LLC, the lead underwriter and lead book-running manager in the initial public offering of 5,700,000 American Depositary Shares (ADSs) of Xiao-I Corporation (Xiao-I), a leading cognitive artificial intelligence enterprise in China. Each ADS represents one-third of an ordinary share of Xiao-I. The ADSs began trading on the Nasdaq Global Market under the ticker symbol "AIXI" on March 9, 2023. The Team advising on the offering was led by Arila Zhou and Anna Jinhua Wang, and included Ze'-ev D. Eiger, Eve Hongye Mao and Emmett Tan. The Team attended the opening bell ceremony at Nasdaq MarketSite in Times Square on March 9 to celebrate the listing of the ADSs. The offering closed on March 13, 2023. Read more.

        • View article
      • June 10, 2022

        Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Phoenix Motor Inc.

        • » more info

          Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Phoenix Motor Inc.

          Robinson+Cole’s Capital Markets + Securities Team (the Team) represented Prime Number Capital LLC, the lead underwriter in an initial public offering of Phoenix Motor Inc., a California based company that designs, assembles, and integrates electric drive systems and light and medium duty electric vehicles, of 2.1 million shares of common stock at an offering price of $7.50 per share, for aggregate gross proceeds of $15.75 million. The shares began trading on the Nasdaq Capital Market under the ticker symbol “PEV” on June 8, 2022. On June 10, 2022, the Team attended the opening bell ceremony at Nasdaq MarketSite in Times Square to celebrate the listing of PEV common stock. The Team members advising Prime Number on the offering were Arila Zhou, Anna Wang, Eve Mao and Yang Xu. Read more.

      • March 17, 2022

        Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Meihua International Medical Technologies

        • » more info

          Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Meihua International Medical Technologies

          Robinson+Cole’s Capital Markets + Securities Team (the Team) represented Prime Number Capital LLC, the lead underwriter in an initial public offering of Meihua International Medical Technologies (Nasdaq ticker symbol “MHUA”), a manufacturer and provider of disposable medical devices with operating subsidiaries in China. At the closing of the IPO on February 18, 2022, a total of 3,940,000 ordinary shares of MHUA, listed on Nasdaq Global Market, were sold at a public offering price of $10.00 per ordinary share (the "Ordinary Shares"), including 340,000 Ordinary Shares issued pursuant to the partial exercise of the underwriters' over-allotment option, for aggregate gross proceeds of $39.4 million before deducting underwriting discounts and commissions and offering expenses. The successful share sale makes MHUA the first China-based company to list in the U.S. since July 2021. The Team members advising on the offering were Arila Zhou, Mitchell Lampert, Anna Wang, Yang Xu and Eve Mao. Read more.

        • View article